Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or older

Finding safe and effective treatments for chronic hepatitis C virus (HCV) infection in the elderly is of clinical interest given the comorbidities and associated polypharmacy in this population. However, the number of patients older than age 65 years enrolled into clinical trials of anti-HCV medicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Foster, Graham R., Asselah, Tarik, Kopecky-Bromberg, Sarah, Lei, Yang, Asatryan, Armen, Trinh, Roger, Zadeikis, Neddie, Mensa, Federico J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314565/
https://www.ncbi.nlm.nih.gov/pubmed/30601818
http://dx.doi.org/10.1371/journal.pone.0208506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314565/
https://www.ncbi.nlm.nih.gov/pubmed/30601818
http://dx.doi.org/10.1371/journal.pone.0208506

Ejemplares similares